Company / Income Tax
Axsome Therapeutics, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$530.0K
FY2025
5-year range
-$530.0K / $960.0K
FY2021-FY2025
Trend
-723.5%
vs FY2024
Sector context
#179 of 204
Health Care
What the data says
Income Tax changed -724% YoY in FY2025, a notable deviation from the 2-year average annual change of -407%.
Based on SEC 10-K filings.
-$530,000 in FY2025.
Improved from $960,000 to -$530,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 204This company -$530.0K Sector average $118.7M
▼
-100.4% below sector average
Key checks
Key Insights
- In FY2025, income tax decreased 723.5% year-over-year.
- Ranks #179 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$530.0K | -723.5% |
| FY2024 | $85.0K | -91.1% |
| FY2023 | $960.0K | - |
| FY2022 | $0 | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026